Under the favorable policy, domestic pharmaceutical companies are constantly increasing their attention to children's drugs
Time of Update: 2022-10-01
Due to the difficulty of children's clinical research, in China, children's drugs have always had the "four less" situation of few varieties, few dosage forms, few specifications and fewer special dru
The profit of Chinese herbal decoction pieces increased by 102%, and the market size is expected to be further expanded
Time of Update: 2022-08-15
The information-based system completes the transformation from a traditional decoction piece factory to a digital decoction piece factory, fundamentally solves the non-reproducibility of traditional Chinese medicine decoction pieces based on experience, realizes the transparency and traceability of the production process, and fully guarantees the stability of the quality of Chinese medicine decoction pieces , and at the same time improve production efficiency, achieve cost reduction and increase quality and efficiency .
FDA grants AstraZeneca Tezepelumab orphan drug certification for the treatment of EoE
Time of Update: 2021-10-21
In addition, in the subgroup of patients with a baseline eosinophil count of <300 cells/μl, the trial also reached the primary endpoint: compared with placebo+SoC, tezepelumab+SoC treatment made AAER statistically significant and Decrease of clinical significance .
Alzheimer's disease can be latent for 20 years before the onset of disease. Two major measures can help you prevent its progression
Time of Update: 2021-10-01
In 2019, Professor Han Ying's research group carried out a study on non-pharmaceutical intervention therapy of light stimulation for SCD population and normal elderly, and found that light therapy is effective in improving the cognition of the elderly .
Immune combination therapy adds "empirical evidence" to liver cancer
Time of Update: 2021-08-01
This study uses two national major new drug creation special results-Sintilizumab injection and bevacizumab injection for combined treatment, to carry out a randomized, controlled, open multi-center II of first-line treatment for patients with advanced liver cancer /Phase III key clinical study (ORIENT-32) .
The second batch of provincial centralized procurement results in Fujian Province announced the successful bidding of 33 varieties
Time of Update: 2021-06-02
(2) The group with the lowest quotation and the decrease rate meets one of the following two conditions to be selected, and the group will be given 50% of the agreed purchase volume: ①The decrease rate reaches 25% of the average decrease rate of the three and above groups in all groups; ②The absolute decrease rate reaches 10%.
Implementation of the new version of the medical insurance catalogue, 119 national talks officially reduced the price of drugs
Time of Update: 2021-03-23
Tilelizumab: For example, BeiGene's star product tislelizumab (BaiZian), the indication for entering the medical insurance this time is the treatment of relapsed or refractory classic Hodgkin's lymphoma after at least second-line chemotherapy; PD- The failure of platinum-containing chemotherapy with high L1 expression includes the treatment of locally advanced or metastatic urothelial carcinoma that has progressed within 12 months of neoadjuvant or adjuvant chemotherapy.
Hesco cyclophenol injections are approved for listing by the NMPA
Time of Update: 2021-01-06
According to NMPA's official website, recently, NMPA approved the listing of Hesco's declared Class 1 innovative drug cyclophenol injection (commodity name: Sisshuning) through the priority review approval process.
source: MED2.0 China Drug Review Database Cyclophenol is GABAA-subjector astigtor, an anaesthetic sedative.
Shanghai completed the first case of new coronavirus and antibody subjects
Time of Update: 2020-11-25
People's Network Shanghai, June 7 (Ge Junjun) June 5, Shanghai Junshi Biopharmaceutical Technology Co., Ltd. and China Microbiology Research Institute and other units jointly developed the reorganization of the whole human source anti-neo-coronavirus monoclonal antibody injection (hereinafter referred to as "JS016") was approved by the State Drug Administration, into phase I clinical trial stage.
Roche PD-L1, a pharmaceutical speed reading agency, has won the termination of 260 million collaborations between four clinical drug companies in China
Time of Update: 2020-11-14
(Jiangxi Provincial Drug Administration) Part 2 after observation of 260 million two well-known pharmaceutical companies to terminate cooperation 7, Haisco issued a notice, wholly-owned subsidiary Sichuan Haisco on September 4 and Haitron Pharmaceuticals signed a "patent implementation license agreement and related agreements to terminate the agreement." After friendly consultations between the two sides, Sichuan Haisco transferred the original HC-1119 patented products to Haitron Pharmaceuticals, with a total transfer value of RMB260 million, to be paid in three installments.
Politics and Solutions . . Local collection of flower-picking price reduction DIP pay to appear on the supplies country to start the first shot
Time of Update: 2020-11-09
although there are still a large number of injections have not been consistent evaluation, but the clinical procurement of high amounts of injections has become the inter-provincial collection of "the main role", large-scale price reduction is inevitable.
Pangolins become a level of protection of animals, where do these chinese medicines go
Time of Update: 2020-06-27
Guide read: "The emperor, remember the leopard bone of the drug and wine incident?" Xinhua News Agency reported that China will be all species of pangolins by the state secondary protection of wildli
Drug collection enters normal, and the supervision inspection gradually becomes the trend
Time of Update: 2020-06-23
" Pharmaceutical Network Industry Dynamic " Recently, it was reported that The Shaanxi Provincial Drug Administration, in conjunction with the Shaanxi Provincial Medical Insurance Bureau, carried ou
Uber's anti-epileptic innovative drug Vipit® (Lacacaamine tablets) has been approved by the State Drug Administration
Time of Update: 2020-06-10
today, Yousby announced that its anti-epileptic new drug (http:// Vipert ® (Lacacachamine tablets) has been approved by the National Drug (http:// Supervision Authority for adults and adolesce
NMPA approves new HIV compound drug Descovy for treatment of HIV-1 infection in adults and adolescents
Time of Update: 2020-06-10
recently, gilead, the giant of Pharmaceutical (http:// announced that China's National Drug (http:// Regulatory Authority (NMPA) has approved the of the new drug (http:// of HIV complex /Pr